Come up with a name for your new list and we'll add to it:
OMEICOS Therapeutics raised a round of funding on June 08, 2017. Investors include
Bundesministerium fur Bildung und Forschung.
OMEICOS Therapeutics is a biopharmaceutical company developing small molecule therapeutics for the prevention and treatment of cardiovascular diseases. The company has discovered a series of metabolic…